Management of Cataplexy

First-Line Pharmacological Options

The American College of Cardiology is not relevant here, however, Sodium oxybate is the first-line treatment for cataplexy in narcolepsy patients, as it is FDA-approved for treating both cataplexy and excessive daytime sleepiness, according to Praxis Medical Insights 1
Sodium oxybate (Xyrem/Xywav) is administered as a liquid in two divided doses at night, with the first dose at bedtime and the second dose 2.5-4 hours later, as recommended by Praxis Medical Insights 2
Pitolisant, a histamine-3-receptor inverse agonist, is also effective for cataplexy management and has the advantage of not being a controlled substance, according to Praxis Medical Insights 1

Antidepressants are effective for cataplexy control, particularly those affecting norepinephrine and serotonin systems, as stated by the Journal of the American Geriatrics Society (JAGS) 3

For elderly patients, careful monitoring is required when using sodium oxybate due to potential adverse effects, as noted by Praxis Medical Insights 2
Dosing should be initiated at lower levels and titrated more gradually for elderly patients, according to the Journal of the American Geriatrics Society (JAGS) 3

Behavioral modifications can help control cataplexy, including maintaining good sleep hygiene and regular sleep-wake schedules, as recommended by the Journal of the American Geriatrics Society (JAGS) 3
Occupational considerations, such as avoiding shift work and on-call schedules, can also help manage cataplexy, according to the Journal of the American Geriatrics Society (JAGS) and Praxis Medical Insights 3, 4

Regular assessment of cataplexy frequency and severity is necessary, as stated by Praxis Medical Insights 4
Monitor for medication side effects, particularly with sodium oxybate, such as respiratory depression, enuresis, nausea, and headache, as noted by Praxis Medical Insights 2
Watch for cataplexy exacerbation if any medication affecting adrenergic systems is initiated, according to Praxis Medical Insights 1

Primary care physicians should refer patients to a sleep specialist when narcolepsy with cataplexy is suspected, as recommended by Praxis Medical Insights 4

Failure to recognize cataplexy as distinct from seizures or other neurological conditions can lead to misdiagnosis, according to Praxis Medical Insights 4
Inadequate treatment of both excessive daytime sleepiness and cataplexy components can worsen overall symptom burden, as noted by Praxis Medical Insights 4
Sodium oxybate carries an FDA black box warning as it may cause respiratory depression; use with caution in patients with respiratory conditions, as stated by Praxis Medical Insights 2